Organization
InMed Pharmaceuticals
1 clinical trial
Clinical trial
A Randomised, Double-Blind, Vehicle-Controlled Phase 2 Study of Topically Applied INM-755 (Cannabinol) Cream in Patients With Epidermolysis BullosaStatus: Completed, Estimated PCD: 2023-04-03